삼성서울병원

Ko En

Kim, Seok Jin M.D

TITLE
Associate Professor of Hematology and Oncology, Sungkyunkwan University School of Medicine
Samsung Medical Center
Treament Schedule 04 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
AM
PM
Treament Schedule 05 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
SUN
31
AM
PM

Medical School

Korea University College of Medicine

Specialty Training

Fellowship   Korea University Medical Center
Residency   Korea University Anam Hospital
Internship   Korea University Guro Hospital

Other Education

Postdoctoral fellow, Duke University Medical Center, NC, USA

Clinical & Research Interests

Malignant lymphoma, multiple myleoma,stem cell transplantation

Participation in Academic Societies
and Research

American Society of Hematology
Korean Society of Hematology
Koran Cancer Association
Korean Society of Blood and Marrow Transplantation

Selected Publications

  • BONE MARROW TRANSPL 2019 10.1038/s41409-019-0629-7 Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma Lee1, YJ; Moon, JH; Sohn, SK; Kim, SJ; Jung, SH; Lee, JJ; Jo, JC; Shin, HJ; Lee, WS; Lee, JH; Bae, SH; Kim, MK; Lee, HS; Kim, K; Min, CK
    View PubMed
  • ANN HEMATOL 2019 10.1007/s00277-019-03791-y Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma Yi1, JH; Lee, GW; Do, YR; Jung, HR; Hong, JY; Yoon, DH; Suh, C; Choi, YS; Yi, SY; Sohn, BS; Kim, BS; Oh, SY; Park, J; Jo, JC; Lee, SS; Oh, YH; Kim, SJ; Kim, WS
    View PubMed
  • MEDICINE 2019 10.1097/MD.0000000000017641 Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997-2016 An observational study Sim1, J; Takayama, T; Cho, J; Kim, SJ; Kim, WS; Ree, HJ; Ko, YH
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-6303-z Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma Kim1, SJ; Yoon, DH; Kang, HJ; Hong, JY; Lee, HS; Oh, SY; Shin, HJ; Kong, JH; Yi, JH; Sakamoto, K; Ko, YH; Huh, J; Lee, SS; Takeuchi, K; Shin, DY; Suh, C; Kim, WS
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-51522-0 A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study Tan1, KM; Chia, B; Lim, JQ; Khoo, LP; Cheng, CL; Tan, L; Poon, E; Somasundaram, N; Farid, M; Tang, TPL; Tao, M; Cheah, DMZ; Laurensia, Y; Pang, JWL; Song, T; Tan, J; Huang, DC; Kim, SJ; Kim, WS; Ong, CK; Lim, ST; Chan, JY
    View PubMed